Moderna, Merck vaccine with Keytruda delays return of deadly skin cancer after 3 years, data says

Those results build on midstage trial data Moderna and Merck released earlier this year, which examined the efficacy of the combination over a shorter period.

from Health and Science https://ift.tt/gRaJc4w
https://ift.tt/GcsXRDE
https://ift.tt/Oc4yDho